CBD is marketed for sleep, anxiety, pain, recovery, skin health and many other outcomes. The evidence is much narrower than those marketing claims suggest, and consumer CBD products are not equivalent to an FDA-approved prescription medicine.
The most important distinction: prescription CBD vs consumer CBD
The FDA has approved one cannabis-derived prescription drug containing purified cannabidiol, Epidiolex, for seizures associated with specific rare disorders. FDA has not approved other consumer CBD products as treatments for sleep disorders, anxiety, pain, diabetes, cancer, heart disease or other conditions. FDA regulation of cannabis and CBD.
CBD and sleep
CBD is frequently marketed as a sleep aid, but evidence does not justify treating ordinary CBD oils, gummies or tinctures as established insomnia treatments. NCCIH notes that a review of cannabinoid therapies found insufficient evidence to support their use for treating sleep disorders. NCCIH: Sleep disorders and complementary approaches.
CBD and anxiety
Small human studies have explored CBD for anxiety-related outcomes, but findings from a particular dose or controlled study cannot be generalized to every retail CBD product. Product concentration, formulation, THC content, contaminants and labeling accuracy vary.
CBD and pain
Cannabinoids have been studied for chronic pain, but much of that research involves cannabis preparations containing THC, prescription-style formulations or products very different from a typical retail CBD oil. NCCIH describes the evidence as limited and notes that adverse effects are more common with cannabinoid treatment than placebo in some reviews. NCCIH: Cannabis and cannabinoids.
Claims this page no longer makes
The old version of this article claimed or implied that CBD could reduce obesity, prevent heart disease or cancer, protect against Alzheimer’s disease, strengthen bones, treat skin disorders, lower cortisol, treat insomnia and act as a broad anti-inflammatory medicine. Those conclusions were not justified by the evidence cited and have been removed.
Safety and drug interactions
FDA identifies real CBD safety concerns, including potential liver injury, drug interactions and sedation. NCCIH also notes changes in alertness, mood, appetite and gastrointestinal symptoms, along with possible label inaccuracies and contamination in over-the-counter products.
Product quality matters
- A CBD amount printed on a label does not guarantee the product contains exactly that amount.
- THC or contaminants may be present even when consumers do not expect them.
- “Full spectrum,” “broad spectrum,” “hemp extract” and similar terms do not prove effectiveness.
- Third-party testing can improve transparency, but it does not prove a health benefit.
Bottom line
CBD is an active compound with legitimate pharmaceutical research behind it, but that does not validate the sweeping health claims used to market consumer CBD oils. If you are considering CBD for a health or sleep problem—especially if you take medications—discuss it with a qualified healthcare professional and rely on current evidence rather than an affiliate product claim.